NGVT on NYSE
Ingevity Corp
Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us.4 From its latest annual report
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with BALCHEM CORP, Innospec or Ecovyst Inc., or pick any stock.
- TickerNGVT on NYSE2
- IndustryChemicals & Allied Products2
- HeadquartersNorth Charleston, United States2
- Incorporated inDE3
- Business address4920 O'Hear Avenue, Suite 400, North Charleston, Sc 294053
- Filer categoryLarge accelerated filer3
- Legal formCorporation2
- LEI5493009UTFC4B5IMGF872
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O Corporation Service Company, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 57190842
See how the biggest companies compare on our leaderboards
Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. Through a diverse team of talented and experienced people, we develop, manufacture, and bring to market solutions that are largely renewably sourced and help customers solve complex problems while making the world more sustainable. Our products are used in a variety of demanding applications, including automotive gasoline vapor emissions control systems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, elastomers, and paint for road markings. We operate in three reportable segments: Performance Materials, Performance Chemicals and Advanced Polymer Technologies.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
39.5%Gross margin5
35.9%Operating margin5
-14.3%Net margin5
-2.7%Revenue growth, 20255
-562.6%Return on equity5
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Performance Materials brought in 52% of the revenue Ingevity Corp broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Performance Materials | $586.0M | $609.6M | $606.9M |
| Performance Chemicals | $425.5M | $401.9M | $400.5M |
| Advanced Polymer Technologies | $204.0M | $188.6M | $160.2M |
Regions
North America brought in 35% of the revenue Ingevity Corp broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| North America | $672.7M | $651.5M | $665.1M |
| United States | $602.3M | $571.5M | $585.0M |
| Asia Pacific | $323.3M | $325.0M | $298.5M |
| EMEA | $179.9M | $172.4M | $158.9M |
| China | $189.2M | $175.6M | $153.1M |
| South America | $39.6M | $51.2M | $45.1M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue60¢$706.1M
- Research and development2¢$28.4M
- Selling, general and admin15¢$171.2M
- Other costs15¢$175.4M
- Interest7¢$78.3M
- Income tax1¢$8.2M
Out of $1.2B in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Share buybacks17¢$56.3M
- Kept or used elsewhere83¢$274.9M
Out of $331.2M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net sales | $1.2B | $1.2B | $1.2B |
| Cost of sales | $706.1M | $735.3M | $770.5M |
| Gross profit | $461.5M | $464.8M | $445.0M |
| Selling, general, and administrative expenses | $171.2M | $157.8M | $161.8M |
| Research and technical expenses | $28.4M | $24.5M | $25.4M |
| Restructuring and other (income) charges, net | $12.8M | $18.1M | $53.4M |
| Goodwill impairment charge | $183.8M | $306.6M | $0 |
| Long lived asset impairment charge | $109.3M | $0 | $0 |
| Acquisition-related costs | $0 | $300.0K | $3.6M |
| Other (income) expense, net | $25.0M | $7.9M | -$16.2M |
| Interest expense | $78.3M | $97.8M | $93.3M |
| Interest income | -$5.2M | -$7.7M | -$6.3M |
| Income (loss) from continuing operations before income taxes | -$142.1M | -$140.5M | $130.0M |
| Provision (benefit) for income taxes on continuing operations | $8.2M | -$19.1M | $24.2M |
| Net income (loss) from continuing operations | -$150.3M | -$121.4M | $105.8M |
| Income (loss) from discontinued operations, net of income taxes | -$16.8M | -$308.9M | -$111.2M |
| Net income (loss) | -$167.1M | -$430.3M | -$5.4M |
| Basic earnings (loss) per share from continuing operations (usd per share) | -$4 | -$3 | $3 |
| Basic earnings (loss) per share from continuing operations (usd per share) | -$0 | -$9 | -$3 |
| Basic earnings (loss) per share (usd per share) | -$4.61 | -$11.85 | -$0.15 |
| Diluted earnings (loss) per share from continuing operations (usd per share) | -$4 | -$3 | $3 |
| Diluted earnings (loss) per share from discontinued operations (usd per share) | -$0 | -$9 | -$3 |
| Diluted earnings (loss) per share (usd per share) | -$4.61 | -$11.85 | -$0.15 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $78.1M | $68.0M | $95.9M | |
| Accounts receivable, net of allowance of $1.5 - 2025 and $0.6 - 2024 | $127.2M | $131.7M | ||
| Inventories, net | $186.0M | $195.9M | ||
| Prepaid and other current assets | $47.0M | $51.1M | ||
| Current assets of discontinued operations | $15.9M | $46.5M | ||
| Current assets | $454.2M | $493.2M | ||
| Property, plant, and equipment, net | $608.1M | $642.9M | ||
| Operating lease assets, net | $29.5M | $44.7M | ||
| Goodwill | $4.3M | $175.2M | ||
| Other intangibles, net | $176.1M | $278.8M | ||
| Deferred income taxes | $117.0M | $117.9M | ||
| Restricted investment, net of allowance of $0.2 - 2025 and $0.2 - 2024 | $84.4M | $81.6M | ||
| Strategic investments | $83.1M | $87.3M | ||
| Other assets | $74.9M | $79.2M | ||
| Noncurrent assets of discontinued operations | $19.5M | $21.8M | ||
| Total Assets | $1.7B | $2.0B | ||
| Accounts payable | $92.0M | $94.5M | ||
| Accrued expenses | $148.0M | $58.1M | ||
| Accrued payroll and employee benefits | $34.6M | $27.3M | ||
| Current operating lease liabilities | $11.8M | $14.4M | ||
| Notes payable and current maturities of long-term debt | $47.1M | $61.3M | ||
| Income taxes payable | $4.7M | $5.6M | ||
| Current liabilities of discontinued operations | $3.1M | $2.9M | ||
| Current liabilities | $341.3M | $264.1M | ||
| Long-term debt including finance lease obligations | $1.2B | $1.3B | ||
| Noncurrent operating lease liabilities | $22.4M | $33.6M | ||
| Deferred income taxes | $55.1M | $56.2M | ||
| Other liabilities | $40.5M | $130.6M | ||
| Noncurrent liabilities of discontinued operations | $700.0K | $3.2M | ||
| Total Liabilities | $1.6B | $1.8B | ||
| Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2025 and 2024) | $0 | $0 | ||
| Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,891,710 and 43,630,211 issued and 35,485,876 and 36,350,425 outstanding at 2025 and 2024, respectively) | $400.0K | $400.0K | ||
| Additional paid-in capital | $195.7M | $176.8M | ||
| Retained earnings | $404.9M | $572.0M | ||
| Accumulated other comprehensive income (loss) | $500.0K | -$41.4M | ||
| Treasury stock, common stock, at cost (8,405,834 shares - 2025 and 7,279,786 shares - 2024) | -$571.8M | -$512.6M | ||
| Total Equity | $29.7M | $195.2M | $631.4M | $698.3M |
| Total Liabilities and Equity | $1.7B | $2.0B | ||
| Allowance for accounts receivable | $1.5M | $600.0K | ||
| Held-to-maturity, allowance for credit loss | $200.0K | $200.0K | ||
| Preferred stock, par value (usd per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (shares) | 50.0M shares | 50.0M shares | ||
| Preferred stock, shares issued (shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (shares) | 0 shares | 0 shares | ||
| Common stock, par value (usd per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (shares) | 300.0M shares | 300.0M shares | ||
| Common stock, shares issued (shares) | 43.9M shares | 43.6M shares | ||
| Common stock shares outstanding (shares) | 35.5M shares | 36.4M shares | ||
| Treasury stock (shares) | 8.4M shares | 7.3M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $78.1M | $68.0M | $95.9M | |
| Accounts receivable, net of allowance of $1.5 - 2025 and $0.6 - 2024 | $127.2M | $131.7M | ||
| Inventories, net | $186.0M | $195.9M | ||
| Prepaid and other current assets | $47.0M | $51.1M | ||
| Current assets of discontinued operations | $15.9M | $46.5M | ||
| Current assets | $454.2M | $493.2M | ||
| Property, plant, and equipment, net | $608.1M | $642.9M | ||
| Operating lease assets, net | $29.5M | $44.7M | ||
| Goodwill | $4.3M | $175.2M | ||
| Other intangibles, net | $176.1M | $278.8M | ||
| Deferred income taxes | $117.0M | $117.9M | ||
| Restricted investment, net of allowance of $0.2 - 2025 and $0.2 - 2024 | $84.4M | $81.6M | ||
| Strategic investments | $83.1M | $87.3M | ||
| Other assets | $74.9M | $79.2M | ||
| Noncurrent assets of discontinued operations | $19.5M | $21.8M | ||
| Total Assets | $1.7B | $2.0B | ||
| Accounts payable | $92.0M | $94.5M | ||
| Accrued expenses | $148.0M | $58.1M | ||
| Accrued payroll and employee benefits | $34.6M | $27.3M | ||
| Current operating lease liabilities | $11.8M | $14.4M | ||
| Notes payable and current maturities of long-term debt | $47.1M | $61.3M | ||
| Income taxes payable | $4.7M | $5.6M | ||
| Current liabilities of discontinued operations | $3.1M | $2.9M | ||
| Current liabilities | $341.3M | $264.1M | ||
| Long-term debt including finance lease obligations | $1.2B | $1.3B | ||
| Noncurrent operating lease liabilities | $22.4M | $33.6M | ||
| Deferred income taxes | $55.1M | $56.2M | ||
| Other liabilities | $40.5M | $130.6M | ||
| Noncurrent liabilities of discontinued operations | $700.0K | $3.2M | ||
| Total Liabilities | $1.6B | $1.8B | ||
| Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2025 and 2024) | $0 | $0 | ||
| Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,891,710 and 43,630,211 issued and 35,485,876 and 36,350,425 outstanding at 2025 and 2024, respectively) | $400.0K | $400.0K | ||
| Additional paid-in capital | $195.7M | $176.8M | ||
| Retained earnings | $404.9M | $572.0M | ||
| Accumulated other comprehensive income (loss) | $500.0K | -$41.4M | ||
| Treasury stock, common stock, at cost (8,405,834 shares - 2025 and 7,279,786 shares - 2024) | -$571.8M | -$512.6M | ||
| Total Equity | $29.7M | $195.2M | $631.4M | $698.3M |
| Total Liabilities and Equity | $1.7B | $2.0B | ||
| Allowance for accounts receivable | $1.5M | $600.0K | ||
| Held-to-maturity, allowance for credit loss | $200.0K | $200.0K | ||
| Preferred stock, par value (usd per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (shares) | 50.0M shares | 50.0M shares | ||
| Preferred stock, shares issued (shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (shares) | 0 shares | 0 shares | ||
| Common stock, par value (usd per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (shares) | 300.0M shares | 300.0M shares | ||
| Common stock, shares issued (shares) | 43.9M shares | 43.6M shares | ||
| Common stock shares outstanding (shares) | 35.5M shares | 36.4M shares | ||
| Treasury stock (shares) | 8.4M shares | 7.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | -$167.1M | -$430.3M | -$5.4M |
| Depreciation and amortization | $106.4M | $108.3M | $122.8M |
| Non cash operating lease costs | $14.7M | $19.1M | $18.6M |
| Deferred income taxes | -$4.7M | -$121.4M | -$44.7M |
| Disposal/impairment of assets | $3.2M | $1.3M | $4.3M |
| Restructuring and other (income) charges, net | $55.7M | $186.2M | $170.2M |
| CTO resales | $0 | $52.7M | $22.0M |
| LIFO liquidation | -$6.8M | -$5.8M | -$28.5M |
| Share-based compensation | $18.3M | $11.9M | $10.6M |
| (Gain) loss on strategic investment | $26.2M | $11.4M | -$19.3M |
| Pension and other postretirement benefit costs | $1.2M | $1.5M | $1.6M |
| Goodwill impairment charge | $183.8M | $349.1M | $0 |
| Impairment, long-lived asset, held-for-use | $109.3M | $0 | $0 |
| Other non-cash items | $7.6M | $17.0M | $36.2M |
| Accounts receivable, net | $12.2M | $38.2M | $42.7M |
| Inventories, net | $40.2M | $73.3M | $25.8M |
| Prepaid and other current assets | $1.3M | $7.7M | -$28.6M |
| Planned major maintenance outage | -$6.5M | -$6.5M | -$12.8M |
| Accounts payable | -$2.6M | -$63.4M | -$14.6M |
| Accrued expenses | -$14.1M | -$1.0M | -$7.7M |
| Accrued payroll and employee benefits | $6.9M | $8.0M | -$33.5M |
| Income taxes | -$1.2M | -$13.8M | $6.4M |
| Operating leases | -$19.5M | -$21.7M | -$22.5M |
| Restructuring and other spending | -$46.1M | -$59.3M | -$44.0M |
| CTO resales | $6.2M | -$46.1M | -$10.6M |
| Changes in all other operating assets and liabilities, net | $6.6M | $12.2M | $16.1M |
| Net cash provided by (used in) operating activities | $331.2M | $128.6M | $205.1M |
| Capital expenditures | -$57.7M | -$77.6M | -$109.8M |
| Proceeds from disposition of assets | $3.6M | $0 | |
| Sale (purchase) of strategic investments, net | -$16.4M | -$300.0K | $29.1M |
| Restricted investment | $13.0M | $0 | $7.0M |
| Other investing activities, net | $0 | -$1.6M | -$3.6M |
| Net cash provided by (used in) investing activities | -$57.5M | -$79.5M | -$77.3M |
| Proceeds from revolving credit facility and other borrowings | $291.3M | $404.5M | $376.3M |
| Payments on revolving credit facility and other borrowings | -$483.6M | -$470.6M | -$382.9M |
| Debt issuance costs | $0 | $0 | -$400.0K |
| Financing lease obligations, net | -$1.3M | -$1.0M | -$700.0K |
| Tax payments related to withholdings on vested equity awards | -$3.7M | -$3.1M | -$4.8M |
| Proceeds and withholdings from share-based compensation plans, net | $1.4M | $0 | $4.7M |
| Repurchases of common stock under publicly announced plan | -$56.3M | $0 | -$92.1M |
| Net cash provided by (used in) financing activities | -$252.2M | -$70.2M | -$99.9M |
| Increase (decrease) in cash, cash equivalents, and restricted cash | $21.5M | -$21.1M | $27.9M |
| Effect of exchange rate changes on cash | $4.5M | -$4.2M | -$300.0K |
| Change in cash, cash equivalents, and restricted cash | $26.0M | -$25.3M | $27.6M |
| Cash paid for interest, net of capitalized interest | $70.4M | $85.4M | $82.7M |
| Cash paid for income taxes, net of refunds | $10.9M | $26.9M | $29.7M |
| Purchases of property, plant, and equipment in accounts payable | $1.7M | $2.4M | $2.8M |
| Leased assets obtained in exchange for new finance lease liabilities | $0 | $0 | $200.0K |
| Leased assets obtained in exchange for new operating lease liabilities | $1.8M | $6.0M | $29.1M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Ingevity Corp, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
20202025
- Chief executive officerLuis M. Fernandez Oct 4, 2024 to Oct 4, 202413
- Chief executive officerJohn C. Fortson Mar 2, 2021 to Mar 1, 202414
- Chief executive officerRichard B. Kelson Mar 3, 2020 to Apr 28, 202015
- PresidentLuis M. Fernandez Oct 4, 2024 to Oct 4, 202413
- PresidentJohn C. Fortson Mar 2, 2021 to Mar 1, 202414
- PresidentRichard B. Kelson Mar 3, 2020 to Apr 28, 202015
- Chief financial officerPhillip John Platt Jul 28, 2026 to now16
- Chief financial officerMary Dean Hall Apr 19, 2021 to Jul 28, 202617
- Chief financial officerJohn C. Fortson Apr 25, 2016 to Mar 2, 202118
Board members and other officers (29)
- VP, Chief Accounting OfficerRyan Joseph Cotterman Jun 24, 2026 to now19
- SVP and Pres, APTMichael N. Shukov Mar 20, 2025 to now20
- SVP and Pres, Perf MaterialsRuth Castillo Nov 25, 2025 to now21
- SVP, OperationsClarence Reid Clontz Jr. Dec 18, 2025 to now22
- VP, CHRO, Dep Gen Coun & CCORyan C. Fisher Apr 8, 2024 to now23
- SVP, Chief HR OfficerTerrence M. Dyer Aug 13, 2024 to now24
- SVP, Perf Chem and Pres, EPSteven Paul Hulme Jan 10, 2022 to now25
- Chief Growth & Innov OfficerErik Spencer Ripple May 6, 2022 to Mar 1, 202326
- SVP, Chief HR OfficerChristine Stunyo Jun 27, 2022 to Mar 1, 202427
- EVP, Gen. Counsel & SecretaryStacy Cozad Feb 2, 2021 to Mar 1, 202428
- CAO & Corporate ControllerPhillip John Platt May 16, 2016 to now29
- EVP, President Perf MaterialsStuart Edward Woodcock Jr. May 16, 2016 to now30
- Board memberFrancis David Segal May 5, 2025 to now31
- Board memberJ. Kevin Willis Dec 19, 2024 to now32
- Board memberBruce D. Hoechner Feb 21, 2023 to now33
- Board memberBenjamin G. Wright Jul 27, 2022 to now34
- Board memberWilliam J. Slocum Jul 27, 2022 to Sep 29, 202335
- Board memberJohn C. Fortson Mar 2, 2021 to Mar 1, 202414
- Board memberDiane H. Gulyas Feb 26, 2019 to now36
- Board memberKaren G. Narwold Feb 26, 2019 to now37
- Board memberSteven C. Voorhees Apr 25, 2016 to May 16, 201638
- Board memberWard H. Dickson Apr 25, 2016 to May 16, 201639
- Board memberJean S. Blackwell May 2, 2016 to now40
- Board memberDaniel F. Sansone May 16, 2016 to now41
- Board memberFrederick J. Lynch May 16, 2016 to now42
- Board memberJ. Michael Fitzpatrick May 16, 2016 to May 2, 202243
- Board memberLuis M. Fernandez May 16, 2016 to now44
- Board memberRichard B. Kelson May 16, 2016 to Apr 28, 202045
- General counselKatherine Pryor Burgeson Apr 25, 2016 to Mar 6, 202046
Timeline
Filings
356 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 54 major events, 210 insider forms, 24 large holders, 48 other. The latest 20:
- Oct 2, 20264 EDGAR
- Oct 2, 20264 EDGAR
- Aug 18, 20264 EDGAR
- Aug 14, 20264 EDGAR
- Aug 12, 2026144 EDGAR
- Aug 11, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 3, 2026144 EDGAR
- Jul 30, 202610-Q EDGAR
- Jul 29, 20268-K EDGAR
- Jul 28, 20264 EDGAR
- Jul 8, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jun 24, 20264 EDGAR
- Jun 24, 20263 EDGAR
- Jun 24, 20268-K EDGAR
- Jun 1, 20264 EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 7, 202610-Q EDGAR
The 356 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
13 open-market trades by officers, directors and large owners since October 2021: 0 buys and 13 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Li David HPresident & CEO | Sale | 92 | $74.71 | $6.9K | Form 4 |
| Aug 17, 2026 | Li David HPresident & CEO | Sale | 5,000 | $75.83 | $379.1K | Form 4 |
| Aug 14, 2026 | Li David HPresident & CEO | Sale | 5,000 | $75.73 | $378.6K | Form 4 |
| Aug 13, 2026 | Li David HPresident & CEO | Sale | 5,000 | $75.73 | $378.6K | Form 4 |
| Aug 12, 2026 | Li David HPresident & CEO | Sale | 5,000 | $76.62 | $383.1K | Form 4 |
| Aug 3, 2026 | Fisher Ryan C.SVP, Gen. Counsel & Secretary | Sale | 2,709 | $73.72 | $199.7K | Form 4 |
| May 28, 2026 | DYER TERRANCE MSVP, Chief HR Officer | Sale | 496 | $68.49 | $34.0K | Form 4 |
| Mar 7, 2023 | White Richard Allen JRSVP and Pres, Perf Chemicals | Sale | 1,439 | $81.00 | $116.6K | Form 4 |
| Mar 2, 2023 | WOODCOCK STUART EDWARD JR.EVP, President Perf Materials | Sale | 4,968 | $82.14 | $408.1K | Form 4 |
| Mar 2, 2023 | PLATT PHILLIP JOHNSVP, Chief Financial Officer | Sale | 8,847 | $81.71 | $722.9K | Form 4 |
| Dec 2, 2022 | Ripple Erik SpencerChief Growth and Innovation Of | Sale | 856 | $77.84 | $66.6K | Form 4 |
| Dec 1, 2022 | White Richard Allen JRSVP and Pres, Perf Chemicals | Sale | 1,639 | $77.97 | $127.8K | Form 4 |
| Nov 8, 2021 | Smith Michael P.EVP, President Perf Chemicals | Sale | 7,878 | $80.81 | $636.6K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Wellington Management CompanySCHEDULE 13G/A, 3 filings Feb 4, 2022 to May 15, 202647
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202648
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202649
- VANGUARD GROUP INCSCHEDULE 13G/A, 7 filings Feb 10, 2022 to Mar 27, 202650
- VICTORY CAPITAL MANAGEMENT INCSCHEDULE 13G/A, 2 filings Feb 7, 2024 to Oct 24, 202551
- INCLUSIVE CAPITAL PARTNERS, L.P.SC 13D/A, 4 filings Apr 7, 2022 to Feb 28, 202452
- Boston PartnersSC 13G/A, 1 filing Feb 14, 202253
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 5,364,204 | $400.5M | 0.0% | +66,489 |
| Vanguard Portfolio Management LLC | 2,376,803 | $177.5M | 0.0% | +200,072 |
| Vanguard Capital Management LLC | 1,571,127 | $117.3M | 0.0% | −10,744 |
| State Street Corp | 1,497,321 | $111.8M | 0.0% | +38,086 |
| American Century Companies Inc | 1,270,958 | $94.9M | 0.0% | −161,608 |
| Wellington Management Group Llp | 1,075,514 | $80.3M | 0.0% | −418,778 |
| Segall Bryant & Hamill, LLC | 1,054,605 | $78.7M | 0.9% | −54,443 |
| Millennium Management LLC | 992,049 | $74.1M | 0.1% | −163,323 |
| Brown Advisory Inc | 974,107 | $72.7M | 0.1% | −17,909 |
| Royce & Associates LP | 940,417 | $70.2M | 0.6% | +56,890 |
| Geode Capital Management, LLC | 919,109 | $68.6M | 0.0% | +31,998 |
| Simcoe Capital Management, LLC | 894,072 | $66.8M | 13.0% | −87,943 |
| Dimensional Fund Advisors LP | 787,776 | $58.8M | 0.0% | −10,933 |
| Principal Financial Group Inc | 761,985 | $56.9M | 0.0% | +83,948 |
| Harvey Partners, LLC | 734,307 | $54.8M | 3.8% | −9,193 |
| Victory Capital Management Inc | 680,912 | $50.8M | 0.0% | −60,252 |
| Goldman Sachs Group Inc | 632,506 | $47.2M | 0.0% | +58,129 |
| Maple Rock Capital Partners Inc. | 603,303 | $45.0M | 0.9% | No change |
| Charles Schwab Investment Management Inc | 541,400 | $40.4M | 0.0% | −66,852 |
| Vision One Management Partners, LP | 535,082 | $40.0M | 14.4% | +16,981 |
| Northern Trust Corp | 407,927 | $30.5M | 0.0% | +14,427 |
| Boston Partners | 389,683 | $29.1M | 0.0% | +9,684 |
| Rice Hall James & Associates, LLC | 351,203 | $26.2M | 1.3% | +6,065 |
| Invesco Ltd. | 330,421 | $24.7M | 0.0% | +39,729 |
| Morgan Stanley | 325,811 | $24.3M | 0.0% | +52,058 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIngevity Corp filings on SEC EDGAR
- 2
- 3SEC EDGARIngevity Corp filings on SEC EDGAR
- 4
- 5SEC EDGARIngevity Corp 10-K for fiscal 2025
- 6SEC EDGARIngevity Corp 10-K for fiscal 2019
- 7SEC EDGARIngevity Corp 10-K for fiscal 2020
- 8SEC EDGARIngevity Corp 10-K for fiscal 2021
- 9SEC EDGARIngevity Corp 10-K for fiscal 2022
- 10SEC EDGARIngevity Corp 10-Q for fiscal 2026
- 11SEC EDGARIngevity Corp 10-Q for fiscal 2026
- 12SEC EDGARIngevity Corp 10-K for fiscal 2019
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20SEC EDGARMichael N. Shukov, SVP and Pres, APT
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31SEC EDGARFrancis David Segal, Board member
- 32SEC EDGARJ. Kevin Willis, Board member
- 33SEC EDGARBruce D. Hoechner, Board member
- 34SEC EDGARBenjamin G. Wright, Board member
- 35SEC EDGARWilliam J. Slocum, Board member
- 36SEC EDGARDiane H. Gulyas, Board member
- 37SEC EDGARKaren G. Narwold, Board member
- 38SEC EDGARSteven C. Voorhees, Board member
- 39SEC EDGARWard H. Dickson, Board member
- 40SEC EDGARJean S. Blackwell, Board member
- 41SEC EDGARDaniel F. Sansone, Board member
- 42SEC EDGARFrederick J. Lynch, Board member
- 43SEC EDGARJ. Michael Fitzpatrick, Board member
- 44SEC EDGARLuis M. Fernandez, Board member
- 45SEC EDGARRichard B. Kelson, Board member
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53